Driehaus Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-94,945
| Closed | -$9.68M | – | 461 |
|
|
2023
Q2 | $9.68M | Buy |
+94,945
| New | +$9.68M | 0.12% | 218 |
|
|
2020
Q2 | – | Sell |
-12,558
| Closed | -$1.81M | – | 493 |
|
|
2020
Q1 | $1.81M | Sell |
12,558
-3,740
| -23% | -$540K | 0.06% | 239 |
|
|
2019
Q4 | $3.33M | Sell |
16,298
-197,077
| -92% | -$40.3M | 0.09% | 225 |
|
|
2019
Q3 | $17.1M | Sell |
213,375
-23,264
| -10% | -$1.87M | 0.56% | 45 |
|
|
2019
Q2 | $22.3M | Buy |
236,639
+91,817
| +63% | +$8.66M | 0.7% | 34 |
|
|
2019
Q1 | $12.4M | Buy |
144,822
+16,523
| +13% | +$1.41M | 0.46% | 60 |
|
|
2018
Q4 | $7.2M | Sell |
128,299
-58,528
| -31% | -$3.28M | 0.31% | 94 |
|
|
2018
Q3 | $15.3M | Buy |
+186,827
| New | +$15.3M | 0.47% | 57 |
|